Neuroendocrine carcinoma of the cervix: the value of postoperative radiation in early-stage disease

Objective The current treatment for early-stage neuroendocrine carcinoma of the cervix (NECC) mainly relies on operation and chemotherapy. We want to evaluate values of postoperative radiation in early-stage NECC.Methods Retrospective cohort study. Early-stage NECC patients from 2006 to 2022 in our...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaochen Song, Hui Zhang, Sen Zhong, Xianjie Tan, Shuiqing Ma, Ying Jin, Lingya Pan, Ming Wu, Dongyan Cao, Jiaxin Yang, Yang Xiang
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Annals of Medicine
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/07853890.2025.2466667
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850263651053731840
author Xiaochen Song
Hui Zhang
Sen Zhong
Xianjie Tan
Shuiqing Ma
Ying Jin
Lingya Pan
Ming Wu
Dongyan Cao
Jiaxin Yang
Yang Xiang
author_facet Xiaochen Song
Hui Zhang
Sen Zhong
Xianjie Tan
Shuiqing Ma
Ying Jin
Lingya Pan
Ming Wu
Dongyan Cao
Jiaxin Yang
Yang Xiang
author_sort Xiaochen Song
collection DOAJ
description Objective The current treatment for early-stage neuroendocrine carcinoma of the cervix (NECC) mainly relies on operation and chemotherapy. We want to evaluate values of postoperative radiation in early-stage NECC.Methods Retrospective cohort study. Early-stage NECC patients from 2006 to 2022 in our hospital were included and divided into Postoperative non-radiation group (Group A) and Postoperative radiation group (Group B). We use Kaplan-Meier method to analyze the progression-free survival (PFS), overall survival (OS), recurrence and OS rate.Results Sixty-six cases were included, 32 (48.5%) in Group A and 34 (51.5%) in Group B. After 35 (range 12–116) months follow-up, 26 (39.4%) had recurrence. Compared with Group A, Group B had lower pelvic recurrence rate (12.5% vs 2.9%, p = 0.142), higher distant recurrence rate (28.1% vs 44.1%, p = 0.177), and similar mortality rate (29.4% vs 31.3%, p = 0.871). Postoperative radiation in patients with cervical stromal invasion ≥1/2 showed an extended trend in PFS (33.9 months vs 47.9 months) and OS (40.7 months vs 70.0 months) but without statistical difference (p = 0.963, p = 0.636). Lymph-vascular space invasion (LVSI) is a high-risk factor for tumour recurrence (HR 9.13, p = 0.005), but radiation after surgery did not improve the PFS (51.5 months vs 48.8 months, p = 0.942) and OS (53.9 months vs 60.6 months, p = 0.715) in patients with LVSI.Limitations Retrospective study and relative small sample size.Conclusions Postoperative radiation seems to prolong PFS and OS in patients with cervical stromal invasion ≥1/2. LVSI was a high-risk factor for tumour recurrence, but radiation after surgery in patients with LVSI seems have no survival benefits.
format Article
id doaj-art-e0073aa6e50b406ea24deea91ecc1db9
institution OA Journals
issn 0785-3890
1365-2060
language English
publishDate 2025-12-01
publisher Taylor & Francis Group
record_format Article
series Annals of Medicine
spelling doaj-art-e0073aa6e50b406ea24deea91ecc1db92025-08-20T01:54:55ZengTaylor & Francis GroupAnnals of Medicine0785-38901365-20602025-12-0157110.1080/07853890.2025.2466667Neuroendocrine carcinoma of the cervix: the value of postoperative radiation in early-stage diseaseXiaochen Song0Hui Zhang1Sen Zhong2Xianjie Tan3Shuiqing Ma4Ying Jin5Lingya Pan6Ming Wu7Dongyan Cao8Jiaxin Yang9Yang Xiang10Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, National Clinical Research Center for Obstetric & Gynecologic Diseases, Beijing, ChinaDepartment of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaDepartment of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, National Clinical Research Center for Obstetric & Gynecologic Diseases, Beijing, ChinaDepartment of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, National Clinical Research Center for Obstetric & Gynecologic Diseases, Beijing, ChinaDepartment of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, National Clinical Research Center for Obstetric & Gynecologic Diseases, Beijing, ChinaDepartment of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, National Clinical Research Center for Obstetric & Gynecologic Diseases, Beijing, ChinaDepartment of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, National Clinical Research Center for Obstetric & Gynecologic Diseases, Beijing, ChinaDepartment of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, National Clinical Research Center for Obstetric & Gynecologic Diseases, Beijing, ChinaDepartment of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, National Clinical Research Center for Obstetric & Gynecologic Diseases, Beijing, ChinaDepartment of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, National Clinical Research Center for Obstetric & Gynecologic Diseases, Beijing, ChinaDepartment of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, National Clinical Research Center for Obstetric & Gynecologic Diseases, Beijing, ChinaObjective The current treatment for early-stage neuroendocrine carcinoma of the cervix (NECC) mainly relies on operation and chemotherapy. We want to evaluate values of postoperative radiation in early-stage NECC.Methods Retrospective cohort study. Early-stage NECC patients from 2006 to 2022 in our hospital were included and divided into Postoperative non-radiation group (Group A) and Postoperative radiation group (Group B). We use Kaplan-Meier method to analyze the progression-free survival (PFS), overall survival (OS), recurrence and OS rate.Results Sixty-six cases were included, 32 (48.5%) in Group A and 34 (51.5%) in Group B. After 35 (range 12–116) months follow-up, 26 (39.4%) had recurrence. Compared with Group A, Group B had lower pelvic recurrence rate (12.5% vs 2.9%, p = 0.142), higher distant recurrence rate (28.1% vs 44.1%, p = 0.177), and similar mortality rate (29.4% vs 31.3%, p = 0.871). Postoperative radiation in patients with cervical stromal invasion ≥1/2 showed an extended trend in PFS (33.9 months vs 47.9 months) and OS (40.7 months vs 70.0 months) but without statistical difference (p = 0.963, p = 0.636). Lymph-vascular space invasion (LVSI) is a high-risk factor for tumour recurrence (HR 9.13, p = 0.005), but radiation after surgery did not improve the PFS (51.5 months vs 48.8 months, p = 0.942) and OS (53.9 months vs 60.6 months, p = 0.715) in patients with LVSI.Limitations Retrospective study and relative small sample size.Conclusions Postoperative radiation seems to prolong PFS and OS in patients with cervical stromal invasion ≥1/2. LVSI was a high-risk factor for tumour recurrence, but radiation after surgery in patients with LVSI seems have no survival benefits.https://www.tandfonline.com/doi/10.1080/07853890.2025.2466667Neuroendocrine carcinomacervical cancerradical hysterectomypostoperative radiation therapyoverall survival
spellingShingle Xiaochen Song
Hui Zhang
Sen Zhong
Xianjie Tan
Shuiqing Ma
Ying Jin
Lingya Pan
Ming Wu
Dongyan Cao
Jiaxin Yang
Yang Xiang
Neuroendocrine carcinoma of the cervix: the value of postoperative radiation in early-stage disease
Annals of Medicine
Neuroendocrine carcinoma
cervical cancer
radical hysterectomy
postoperative radiation therapy
overall survival
title Neuroendocrine carcinoma of the cervix: the value of postoperative radiation in early-stage disease
title_full Neuroendocrine carcinoma of the cervix: the value of postoperative radiation in early-stage disease
title_fullStr Neuroendocrine carcinoma of the cervix: the value of postoperative radiation in early-stage disease
title_full_unstemmed Neuroendocrine carcinoma of the cervix: the value of postoperative radiation in early-stage disease
title_short Neuroendocrine carcinoma of the cervix: the value of postoperative radiation in early-stage disease
title_sort neuroendocrine carcinoma of the cervix the value of postoperative radiation in early stage disease
topic Neuroendocrine carcinoma
cervical cancer
radical hysterectomy
postoperative radiation therapy
overall survival
url https://www.tandfonline.com/doi/10.1080/07853890.2025.2466667
work_keys_str_mv AT xiaochensong neuroendocrinecarcinomaofthecervixthevalueofpostoperativeradiationinearlystagedisease
AT huizhang neuroendocrinecarcinomaofthecervixthevalueofpostoperativeradiationinearlystagedisease
AT senzhong neuroendocrinecarcinomaofthecervixthevalueofpostoperativeradiationinearlystagedisease
AT xianjietan neuroendocrinecarcinomaofthecervixthevalueofpostoperativeradiationinearlystagedisease
AT shuiqingma neuroendocrinecarcinomaofthecervixthevalueofpostoperativeradiationinearlystagedisease
AT yingjin neuroendocrinecarcinomaofthecervixthevalueofpostoperativeradiationinearlystagedisease
AT lingyapan neuroendocrinecarcinomaofthecervixthevalueofpostoperativeradiationinearlystagedisease
AT mingwu neuroendocrinecarcinomaofthecervixthevalueofpostoperativeradiationinearlystagedisease
AT dongyancao neuroendocrinecarcinomaofthecervixthevalueofpostoperativeradiationinearlystagedisease
AT jiaxinyang neuroendocrinecarcinomaofthecervixthevalueofpostoperativeradiationinearlystagedisease
AT yangxiang neuroendocrinecarcinomaofthecervixthevalueofpostoperativeradiationinearlystagedisease